D'Ursi P - Search Results

1

An innovative strategy to investigate microbial protein modifications in a reliable fast and sensitive way: A therapy oriented proof of concept based on UV-C irradiation of SARS-CoV-2 spike protein.

Strizzi S, Bernardo L, D'Ursi P, Urbinati C, Bianco A, Limanaqi F, Manconi A, Milanesi M, Macchi A, Di Silvestre D, Cavalleri A, Pareschi G, Rusnati M, Clerici M, Mauri P, Biasin M. Strizzi S, et al. Among authors: d ursi p. Pharmacol Res. 2023 Aug;194:106862. doi: 10.1016/j.phrs.2023.106862. Epub 2023 Jul 20. Pharmacol Res. 2023. PMID: 37479104 Free article.

2

HIV-1 Tat and Heparan Sulfate Proteoglycans Orchestrate the Setup of in Cis and in Trans Cell-Surface Interactions Functional to Lymphocyte Trans-Endothelial Migration.

Urbinati C, Milanesi M, Lauro N, Bertelli C, David G, D'Ursi P, Rusnati M, Chiodelli P. Urbinati C, et al. Among authors: d ursi p. Molecules. 2021 Dec 10;26(24):7488. doi: 10.3390/molecules26247488. Molecules. 2021. PMID: 34946571 Free PMC article.

3

In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library.

Orro A, Uggeri M, Rusnati M, Urbinati C, Pedemonte N, Pesce E, Moscatelli M, Padoan R, Cichero E, Fossa P, D'Ursi P. Orro A, et al. Eur J Med Chem. 2021 Mar 5;213:113186. doi: 10.1016/j.ejmech.2021.113186. Epub 2021 Jan 13. Eur J Med Chem. 2021. PMID: 33472120

4

Recent Strategic Advances in CFTR Drug Discovery: An Overview.

Rusnati M, D'Ursi P, Pedemonte N, Urbinati C, Ford RC, Cichero E, Uggeri M, Orro A, Fossa P. Rusnati M, et al. Int J Mol Sci. 2020 Mar 31;21(7):2407. doi: 10.3390/ijms21072407. Int J Mol Sci. 2020. PMID: 32244346 Free PMC article. Review.

5

A Bittersweet Computational Journey among Glycosaminoglycans.

Paiardi G, Milanesi M, Wade RC, D'Ursi P, Rusnati M. Paiardi G, et al. Biomolecules. 2021 May 15;11(5):739. doi: 10.3390/biom11050739. Biomolecules. 2021. PMID: 34063530 Free PMC article. Review.

6

Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host.

Caccuri F, Messali S, Bortolotti D, Di Silvestre D, De Palma A, Cattaneo C, Bertelli A, Zani A, Milanesi M, Giovanetti M, Campisi G, Gentili V, Bugatti A, Filippini F, Scaltriti E, Pongolini S, Tucci A, Fiorentini S, d'Ursi P, Ciccozzi M, Mauri P, Rizzo R, Caruso A. Caccuri F, et al. Among authors: d ursi p. Virus Evol. 2022 May 21;8(1):veac042. doi: 10.1093/ve/veac042. eCollection 2022. Virus Evol. 2022. PMID: 35706980 Free PMC article.

7

Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and Rescuing.

Fossa P, Uggeri M, Orro A, Urbinati C, Rondina A, Milanesi M, Pedemonte N, Pesce E, Padoan R, Ford RC, Meng X, Rusnati M, D'Ursi P. Fossa P, et al. Among authors: d ursi p. Int J Mol Sci. 2022 Oct 14;23(20):12274. doi: 10.3390/ijms232012274. Int J Mol Sci. 2022. PMID: 36293130 Free PMC article.

8

Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin.

Rusnati M, Paiardi G, Tobia C, Urbinati C, Lodola A, D'Ursi P, Corrado M, Castelli R, Wade RC, Tognolini M, Chiodelli P. Rusnati M, et al. Among authors: d ursi p. Cancer Gene Ther. 2022 Jul;29(7):908-917. doi: 10.1038/s41417-021-00379-5. Epub 2021 Aug 23. Cancer Gene Ther. 2022. PMID: 34426652 Free PMC article.

9

Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications.

Bugatti A, Paiardi G, Urbinati C, Chiodelli P, Orro A, Uggeri M, Milanesi L, Caruso A, Caccuri F, D'Ursi P, Rusnati M. Bugatti A, et al. Sci Rep. 2019 Oct 31;9(1):15768. doi: 10.1038/s41598-019-52201-w. Sci Rep. 2019. PMID: 31673058 Free PMC article.

10

Correction: Cholenic acid derivative UniPR1331 impairs tumor angiogenesis via blockade of VEGF/VEGFR2 in addition to Eph/ephrin.

Rusnati M, Paiardi G, Tobia C, Urbinati C, Lodola A, D'Ursi P, Corrado M, Castelli R, Wade RC, Tognolini M, Chiodelli P. Rusnati M, et al. Among authors: d ursi p. Cancer Gene Ther. 2022 Jul;29(7):1070. doi: 10.1038/s41417-021-00391-9. Cancer Gene Ther. 2022. PMID: 34593982 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

38 results

Search Page